Endo Health Solutions Inc. (ENDP) said its operating company Qualitest Pharmaceuticals obtained approval from the United States Food and Drug Administration, or FDA, for its Abbreviated New Drug Application for Levetiracetam extended-release tablets, 500mg and 750mg, the generic equivalent of UCB's Keppra XR.
According to IMS Health, the total combined sales for Levetiracetam extended-release tablets, 500mg and 750mg, in the U.S. for the 12 months ending May 31, 2012, were around $124.8 million.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.